Single-cell genomics company Parse Biosciences Inc. was hit with a patent infringement lawsuit Wednesday in Delaware District Court. The suit, filed by Morris, Nichols, Arsht & Tunnell; and Paul, Weiss, Rifkind, Wharton & Garrison on behalf of gene sequencing technology manufacturer 10X Genomics Inc., asserts six patents related to the methods for analyzing nucleic acids from single cells and evaluating chromatin accessibility within genomes at the single cell level. The case is 1:22-cv-01117, 10X Genomics, Inc. v. Parse Biosciences, Inc. et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]